קונבריזה

Country: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

BAZEDOXIFENE AS ACETATE 20 MG

থেকে পাওয়া:

NEOPHARM LTD

এটিসি কোড:

G03XC02

ফার্মাসিউটিকাল ফর্ম:

COATED TABLETS

প্রশাসন রুট:

PER OS

Manufactured by:

PFIZER IRELAND PHARMACEUTICALS

Therapeutic group:

BAZEDOXIFENE

থেরাপিউটিক ইঙ্গিত:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

অনুমোদন তারিখ:

2013-04-01